InterVenn Biosciences

InterVenn Biosciences' mission is to advance a new era of personalized medicine by decoding the human glycoproteome – glycosylated proteins that are responsible for driving protein function – revealing a rich source of biological insights that have the potential to significantly improve drug development and patient outcomes. They have pioneered an artificial intelligence- and machine learning-powered, high-throughput biomarker discovery platform called GlycoVision^™, enabling a high-resolution view into an untapped layer of biology at a clinically meaningful scale for the first time in history.